Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/30421
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMarinescu, Daniel-Costin-
dc.contributor.authorRaghu, Ganesh-
dc.contributor.authorRemy-Jardin, Martine-
dc.contributor.authorTravis, William D-
dc.contributor.authorAdegunsoye, Ayodeji-
dc.contributor.authorBeasley, Mary Beth-
dc.contributor.authorChung, Jonathan H-
dc.contributor.authorChurg, Andrew-
dc.contributor.authorCottin, Vincent-
dc.contributor.authorEgashira, Ryoko-
dc.contributor.authorFernández Pérez, Evans R-
dc.contributor.authorInoue, Yoshikazu-
dc.contributor.authorJohannson, Kerri A-
dc.contributor.authorKazerooni, Ella A-
dc.contributor.authorKhor, Yet H-
dc.contributor.authorLynch, David A-
dc.contributor.authorMüller, Nestor L-
dc.contributor.authorMyers, Jeffrey L-
dc.contributor.authorNicholson, Andrew G-
dc.contributor.authorRajan, Sujeet-
dc.contributor.authorSaito-Koyama, Ryoko-
dc.contributor.authorTroy, Lauren-
dc.contributor.authorWalsh, Simon L F-
dc.contributor.authorWells, Athol U-
dc.contributor.authorWijsenbeek, Marlies S-
dc.contributor.authorWright, Joanne L-
dc.contributor.authorRyerson, Christopher J-
dc.date2022-
dc.date.accessioned2022-06-29T04:15:13Z-
dc.date.available2022-06-29T04:15:13Z-
dc.date.issued2022-06-20-
dc.identifier.citationChest 2022; 162(3): 614-629en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/30421-
dc.description.abstractRecent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how to concurrently apply their respective recommendations within a single patient, where discrimination between these two fibrotic interstitial lung diseases represents a frequent diagnostic challenge. The objective of this document, created by an international group of experts, was to suggest a pragmatic approach on how to apply existing guidelines to distinguish IPF and fHP. Key clinical, radiological, and pathological features described in previous guidelines are integrated in a set of diagnostic algorithms, which are then placed in the broader context of multidisciplinary discussion to guide the generation of a consensus diagnosis. While these algorithms necessarily reflect some uncertainty wherever strong evidence is lacking, they provide insight into the current approach favored by experts in the field based on currently available knowledge. The authors further identify priorities for future research to clarify ongoing uncertainties in the diagnosis of fibrotic interstitial lung diseases.en
dc.language.isoeng-
dc.subjectclinical practice guidelinesen
dc.subjecthypersensitivity pneumonitisen
dc.subjectidiopathic pulmonary fibrosisen
dc.subjectmultidisciplinary discussionen
dc.subjectusual interstitial pneumoniaen
dc.titleIntegration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis.en
dc.typeJournal Articleen_US
dc.identifier.journaltitleChesten
dc.identifier.affiliationRespiratory and Sleep Medicineen
dc.identifier.affiliationDepartment of Medicine, University of British Columbia, Vancouver, BC, Canada..en
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia..en
dc.identifier.affiliationRespiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, Victoria, Australia..en
dc.identifier.affiliationCenter for Interstitial Lung Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA..en
dc.identifier.affiliationDepartment of Thoracic Imaging, Institut Coeur Poumon, Boulevard Jules Leclercq, Lille, France..en
dc.identifier.affiliationDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA..en
dc.identifier.affiliationSection of Pulmonary and Critical Care, Department of Medicine, University of Chicago, IL, USA..en
dc.identifier.affiliationDepartment of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA..en
dc.identifier.affiliationDepartment of Radiology, University of Chicago, IL, USA..en
dc.identifier.affiliationDepartment of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC, Canada..en
dc.identifier.affiliationNational Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, Lyon, France..en
dc.identifier.affiliationDepartment of Radiology, Faculty of Medicine, Saga University, Saga, Japan..en
dc.identifier.affiliationDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, National Jewish Health, Denver, CO, USA..en
dc.identifier.affiliationClinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan..en
dc.identifier.affiliationDepartment of Medicine, University of Calgary, Calgary, AB, Canada..en
dc.identifier.affiliationDepartments of Radiology & Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA..en
dc.identifier.affiliationDepartment of Radiology, National Jewish Health, Denver, CO, USA..en
dc.identifier.affiliationDepartment of Radiology, University of British Columbia, Vancouver, BC, Canada..en
dc.identifier.affiliationDepartment of Pathology, University of Michigan, Ann Arbor, MI, USA..en
dc.identifier.affiliationDepartment of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK..en
dc.identifier.affiliationDepartment of Chest Medicine, Bombay Hospital Institute of Medical Sciences, Bhatia Hospital, Mumbai, India..en
dc.identifier.affiliationDepartment of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan..en
dc.identifier.affiliationNational Heart and Lung Institute, Imperial College, London, UK..en
dc.identifier.affiliationInterstitial Lung Disease Unit, Royal Brompton Hospital, London, UK..en
dc.identifier.affiliationCenter of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, Netherlands..en
dc.identifier.affiliationDepartment of Pathology, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada..en
dc.identifier.affiliationCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada..en
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/35738345/en
dc.identifier.doi10.1016/j.chest.2022.06.013en
dc.type.contentTexten_US
dc.identifier.orcid0000-0002-5434-9342en
dc.identifier.pubmedid35738345-
local.name.researcherKhor, Yet H
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

44
checked on Nov 5, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.